Riverain Technologies
3020 South Tech Boulevard
Miamisburg
Ohio
45342-4860
United States
Tel: 800-990-3387
Fax: 937-425-6493
Website: http://www.riverainmedical.com/
Email: info@riveraintech.com
17 articles about Riverain Technologies
-
Riverain Technologies ClearRead™ CT Selected by the VA's Lung Precision Oncology Program for Early Lung Cancer Detection
11/15/2022
Riverain Technologies, the pioneer of Clear Visual Intelligence™ for chest imaging interpretation, was selected by the Veterans Health Administration to provide its unique imaging interpretation solution, ClearRead™ CT, to the Veteran Affair's Lung Precision Oncology Program.
-
Riverain Technologies™ will Showcase Enhancements to its AI Platform for Lung Nodule Detection at RSNA
11/29/2021
Riverain Technologies™, a leader in artificial intelligence (AI) for early, efficient detection of lung nodules, will showcase its solutions and enhancements at the 107th Annual Radiological Society of North America (RSNA) meeting.
-
Riverain Technologies™ Expands Partnerships for Automated, Efficient End-to-End Lung Cancer Screening Capabilities
11/23/2021
Riverain Technologies ™ Expands Partnerships for Automated, Efficient End-to-End Lung Cancer Screening Capabilities.
-
Imbio and Riverain Technologies Partner to Offer a Comprehensive AI-Powered Lung Health Solution
5/18/2021
Imbio, a leading medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and Riverain Technologies™, a leader in clinical AI for lung nodules, announce a partnership to deliver a more complete lung health solution for clinicians, health systems, and radiology practices
-
Riverain Receives $15 Million Growth Capital Investment
9/17/2019
Riverain Technologies, a leading provider of clinical artificial intelligence software used to efficiently detect lung disease at its earliest stages, has received a $15 million growth investment led by Ping An Global Voyager Fund.
-
Riverain Technologies Advances Clinical A.I. Through Use of Synthetic Training Data
7/17/2018
ClearRead CT is an FDA-Cleared, Patent-Protected, Deep Learning Radiology Solution.
-
Riverain Technologies Issued a U.S. Patent for Vessel Suppression Technology
6/13/2018
Riverain Technologies announced today that the United States Patent and Trademark Office has awarded the company a broad patent for its technology that forms a vessel suppressed, chest CT series using deep learning and synthetic data modeling.
-
Riverain Technologies' ClearRead CT Results Published in the American Journal of Roentgenology
1/24/2018
The study documents the results of a multi-reader, multi-case, blinded reader study that shows the benefits of ClearRead CT both in terms of improved reading efficiency and reading accuracy.
-
Riverain Technologies Release: ClearRead CT Adoption Continues to Accelerate
11/14/2017
Riverain’s ClearRead CT install base has expanded in the U.S. as leading institutions see the value in its efficient and effective detection of lung nodules across all chest CTs, including lung cancer screening exams.
-
Riverain Technologies’ ClearRead CT Software Gains Sales Momentum
4/25/2017
-
Riverain Technologies Release: FDA Clears Way For ClearRead CT Software
9/19/2016
-
Study Shows Riverain Technologies Chest X-Ray CAD Detects Previously Missed Lung Cancers 18 Months Earlier
12/4/2013
-
Riverain Technologies’s ClearRead Applications Gain Popularity, Demonstrating 36 Percent Growth In Adoption Year Over Year
11/19/2013
-
FDA Clears Riverain Technologies' Software for X-Ray Images
1/9/2013
-
Riverain Technologies Receives CE Mark for ClearRead +Confirm
11/26/2012
-
Riverain Technologies’s ClearRead Bone Suppression Software Improves Early Detection of Pneumonia
9/11/2012
-
Riverain Technologies Renames Products, Introduces ClearRead Suite
3/12/2012